Skip to main content
EXOZ
NASDAQ Life Sciences

eXoZymes Registers Up to $37.3M Underwritten Stock-and-Warrant Offering

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$4.4
Mkt Cap
$40.838M
52W Low
$3.24
52W High
$18.4
52W Position info
36% above low
Off High info
76% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

EXOZ sits 36% above its 52-week low of $3.24.

Summary

eXoZymes filed an S-1 for an underwritten offering of common stock plus purchase warrants, registered for up to $37.3M in aggregate. Pricing and share count are not yet set; the raise follows a going-concern warning and carries a warrant overhang plus a potential reset of existing June 2026 warrants.


Key Events · Financing and Capital Events · EXOZ

  • Underwritten Stock-and-Warrant Offering Registered

    The S-1 covers common stock plus purchase warrants (one warrant per two shares, five-year term, immediately exercisable), with Newbridge Securities as sole book-running manager; the filing fee table puts the maximum aggregate offering amount at $37,256,250.

  • Pricing and Share Count Still Blank

    Offering price, share count and warrant exercise price remain placeholders; the assumed combined price for two shares and one warrant equals two times the last reported sale price on the pricing date, and the actual price may be at a discount.

  • Heavy Dilution Against a Going-Concern Backdrop

    The raise follows the going-concern doubt and material weakness previously disclosed in the Q2 2026 10-Q; the prospectus warns investors will suffer immediate and substantial dilution in net tangible book value per share.

  • Existing Warrants Reset to $0.001 on Cheap Stock

    The June 2026 warrants, exercisable at $11.24 from June 5, 2027, reset to $0.001 per share if the company sells stock below $8.99 before June 5, 2027 — a low-priced offering would trigger that reset.


Analysis · EXOZ · Life Sciences

eXoZymes is returning to the equity market with an underwritten deal of common stock bundled with five-year purchase warrants (one warrant per two shares), registered for a maximum aggregate offering amount of $37,256,250. For a company this size, that is a large raise, and it lands on top of a going-concern warning and a material weakness in internal controls previously disclosed in the Q2 2026 10-Q — the cash is needed, but existing holders absorb heavy dilution and a warrant overhang. Terms are still blank: pricing, share count and warrant exercise price will be set with Newbridge at launch, and the assumed combined price is two times the last reported sale price on the pricing date, so the final discount is unknown. Note the June 2026 warrants reset to $0.001 per share if the company sells stock below $8.99 before June 5, 2027 — a cheap-stock offering would trigger that reset and add further dilution. The 180-day lock-up carves out an at-the-market program of up to $40,000,000, so more supply can follow this deal.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EXOZ was trading at $4.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $40.8M. The 52-week trading range was $3.24 to $18.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EXOZ - Latest Insights

EXOZ
Nov 13, 2026, 3:58 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.83
Real-time Price: $3.40 info
Change: -$0.430 (-11%) info
Market Cap: $27.423M info
EXOZ
Nov 09, 2026, 9:00 AM EST
Filing Type: FWP
Importance Score:
7
Price at Filing: $4.40
Real-time Price: $3.40 info
Change: -$1.00 (-23%) info
Market Cap: $27.423M info
EXOZ
Aug 13, 2026, 3:50 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $6.00
Real-time Price: $3.40 info
Change: -$2.60 (-43%) info
Market Cap: $27.423M info
EXOZ
Jul 01, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $3.40 info
Change: -$5.10 (-60%) info
Market Cap: $27.423M info
EXOZ
Jul 01, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $8.50
Real-time Price: $3.40 info
Change: -$5.10 (-60%) info
Market Cap: $27.423M info